4 years ago

Evox Therapeutics Raises £69.2M for Exosome-Based Therapeutics

  • Evox Therapeutics Ltd, an Oxford-based biotech company, has secured £69.2m in Series C funding led by Redmile Group, to advance its exosome-based therapeutics pipeline.

      • ProblemBiotechnology/Pharmaceuticals

      "delivering drugs to hard-to-reach organs such as the brain and central nervous system"

      Solution

      "modifying exosomes using proprietary technology to enable targeted drug delivery"

      Covered on